Clinical Trials Logo

Filter by:
NCT ID: NCT02959567 Not yet recruiting - Clinical trials for Cervix Uteri Dilation

Effectiveness and Safety Evaluation of Aqueduct 100-device

Start date: November 2016
Phase: N/A
Study type: Interventional

Evaluation of efficacy and safety of using Aqueduct -100 - Cervical Dilator Device, focusing on diagnostic or operative hysteroscopies.

NCT ID: NCT02948387 Not yet recruiting - Open Fracture Clinical Trials

Preventing Infections in Orthopaedic Patients

Start date: November 2016
Phase: N/A
Study type: Observational

Determine if antibiotic prophylaxis with intravenous cephalosporin and aminoglycoside in patients with Type II and II open fractures is safe and effective.

NCT ID: NCT02937181 Not yet recruiting - Open Fractures Clinical Trials

Antibiotic Prophylaxis in Open Fractures

Start date: December 2016
Phase: Phase 4
Study type: Interventional

Prospective look at antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures

NCT ID: NCT02933554 Not yet recruiting - Obesity Clinical Trials

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

Start date: June 2024
Phase: N/A
Study type: Interventional

Obesity is an epidemic in the US. With progression of obesity, Nonalcoholic steatohepatitis (NASH) has been a growing public health issue. Presently there is no cure for NASH.Prevention of progression of fibrosis in NASH is crucial, as they are at a high risk for cirrhosis and may need liver transplant. Recent studies have shown that blocking blood vessels to a particular portion of the stomach (bariatric or left gastric artery embolization) can temporarily decrease levels of the appetite inducing hormone ghrelin, and result in weight loss.The purpose of this study is to determine if Left gastric artery embolization (LGAE) in patients with obesity and NASH leads to clinically significant weight loss with improvement of NASH.

NCT ID: NCT02924610 Not yet recruiting - Clinical trials for Social Anxiety Disorder

Brief Intervention to Reduce Fear

Start date: October 2016
Phase: Phase 4
Study type: Interventional

The study will test the efficacy of propranolol or placebo, administered after retrieval of a previously acquired public speaking fear, in reducing fear and avoidance of public speaking.

NCT ID: NCT02896348 Not yet recruiting - Stroke Clinical Trials

Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors

Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this study is to: 1. Assess the usability of the SynPhNe device in a home environment. 2. Evaluate the efficacy of the SynPhNe home use device to improve motor hand function in chronic stroke subjects when used with a few sessions of standard care, as compared to standard care alone.

NCT ID: NCT02886325 Not yet recruiting - Health Behavior Clinical Trials

A Community Based Approach to Reducing Rural Cancer Disparities

Start date: September 2016
Phase: N/A
Study type: Interventional

The overall goal is to develop a culturally appropriate and easy to disseminate educational intervention documented to improve cancer prevention and increase cancer screening behaviors in the rural Midwest.

NCT ID: NCT02880163 Not yet recruiting - Trauma Clinical Trials

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

REVIVE
Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.

NCT ID: NCT02873000 Not yet recruiting - COPD Clinical Trials

Incentive Spirometry in Non-critically Ill Hospitalized Patients With Acute Respiratory Failure

Start date: April 2017
Phase: N/A
Study type: Interventional

To evaluate the use of Incentive Spirometry in Non-critically Ill Hospitalized Patients With Shortness of Breath.

NCT ID: NCT02843854 Not yet recruiting - Clinical trials for Peripheral Artery Disease

Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms

VIVAAA
Start date: October 2016
Phase: Phase 1
Study type: Interventional

This study will assess the safety and efficacy of systemic (IV) administration of escalating doses of allogeneic MSCs in modulating immune cell phenotypes and suppressing aortic inflammation in patients with small AAA. Subjects will be randomized in a 1:1:1 fashion to receive mesenchymal stromal cells (1 million or 3 million MSC/kg) intra-venously or placebo (Plasmalyte A).